Skip to main content

Puckett Dan's Form 4 filing

Shockwave Medical, Inc. (SWAV) · filed Nov 2, 2021

Accession no.
0001209191-21-062462
Filed
Nov 2, 2021
Trade date
Nov 1, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $549.3K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Puckett DanCIK 0001602773Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2021Common StockMOption exerciseAcquired+251$4.03+$1,011.5346,039Direct
Nov 1, 2021Common StockMOption exerciseAcquired+2,249$17.00+$38,23348,288Direct
Nov 1, 2021Common StockSSaleDisposed−149$213.18F2−$31,763.8248,139Direct
Nov 1, 2021Common StockSSaleDisposed−251$215.02F3−$53,970.0247,888Direct
Nov 1, 2021Common StockSSaleDisposed−200$215.91F4−$43,18247,688Direct
Nov 1, 2021Common StockSSaleDisposed−164$217.14F5−$35,610.9647,524Direct
Nov 1, 2021Common StockSSaleDisposed−100$218.43F6−$21,84347,424Direct
Nov 1, 2021Common StockSSaleDisposed−300$219.57F7−$65,87147,124Direct
Nov 1, 2021Common StockSSaleDisposed−151$220.46F8−$33,289.4646,973Direct
Nov 1, 2021Common StockSSaleDisposed−200$221.56F9−$44,31246,773Direct
Nov 1, 2021Common StockSSaleDisposed−835$222.66F10−$185,921.145,938Direct
Nov 1, 2021Common StockSSaleDisposed−150$223.51F11−$33,526.545,788Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 1, 2021Common StockMOption exerciseDisposed−251$0.00$02,259Direct
Nov 1, 2021Common StockMOption exerciseDisposed−2,249$0.00$020,247Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $212.90 to $213.74. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $214.49 to $215.38. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $215.59 to $216.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $216.82 to $217.33. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $217.95 to $218.91. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $219.15 to $220.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $220.19 to $220.96. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $221.25 to $222.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $222.33 to $223.17. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $223.39 to $223.66. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)